Results 201 to 210 of about 114,702 (262)

Egress of CD19(+)CD5(+) cells into peripheral blood following treatment with the Bruton tyrosine kinase inhibitor ibrutinib in mantle cell lymphoma patients.

open access: yesBlood, 2013
B. Chang   +14 more
semanticscholar   +1 more source

Challenges with Bruton’s Tyrosine Kinase Inhibitors Treatment

open access: yesCancer Therapy & Oncology International Journal
openaire   +1 more source

Processing of mitochondrial precursor proteins [PDF]

open access: yes, 1984
Neupert, Walter, Schmidt, Bernd
core  

Home - About - Disclaimer - Privacy